1. Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial. Issue 5 (13th January 2022) Authors: Bonelli, Michael; Mrak, Daniel; Tobudic, Selma; Sieghart, Daniela; Koblischke, Maximilian; Mandl, Peter; Kornek, Barbara; Simader, Elisabeth; Radner, Helga; Perkmann, Thomas; Haslacher, Helmuth; Mayer, Margareta; Hofer, Philipp; Redlich, Kurt; Husar-Memmer, Emma; Fritsch-Stork, Ruth; Thalhammer, ... Journal: Annals of the rheumatic diseases Issue: Volume 81:Issue 5(2022) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Human recombinant soluble ACE2 in severe COVID-19. Issue 11 (November 2020) Authors: Zoufaly, Alexander; Poglitsch, Marko; Aberle, Judith H; Hoepler, Wolfgang; Seitz, Tamara; Traugott, Marianna; Grieb, Alexander; Pawelka, Erich; Laferl, Hermann; Wenisch, Christoph; Neuhold, Stephanie; Haider, Doris; Stiasny, Karin; Bergthaler, Andreas; Puchhammer-Stoeckl, Elisabeth; Mirazimi, Ali... Journal: Lancet Issue: Volume 8:Issue 11(2020) Page Start: 1154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study. Issue 12 (17th August 2022) Authors: Mrak, Daniel; Simader, Elisabeth; Sieghart, Daniela; Mandl, Peter; Radner, Helga; Perkmann, Thomas; Haslacher, Helmuth; Mayer, Margareta; Koblischke, Maximilian; Hofer, Philipp; Göschl, Lisa; Kartnig, Felix; Deimel, Thomas; Kerschbaumer, Andreas; Hummel, Thomas; Kornek, Barbara; Thalhammer, Renat... Journal: Annals of the rheumatic diseases Issue: Volume 81:Issue 12(2022) Page Start: 1750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls. Issue 2 (15th September 2022) Authors: Kartnig, Felix; Mrak, Daniel; Simader, Elisabeth; Tobudic, Selma; Radner, Helga; Mandl, Peter; Göschl, Lisa; Hommer, Nikolaus; Mayer, Margareta; Hofer, Philipp; Hummel, Thomas; Deimel, Thomas; Geßl, Irina; Puchner, Antonia; Kerschbaumer, Andreas; Thalhammer, Renate; Handisurya, Alessandra; Kain, ... Journal: Annals of the rheumatic diseases Issue: Volume 82:Issue 2(2023) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity. Issue 10 (20th July 2021) Authors: Mrak, Daniel; Tobudic, Selma; Koblischke, Maximilian; Graninger, Marianne; Radner, Helga; Sieghart, Daniela; Hofer, Philipp; Perkmann, Thomas; Haslacher, Helmuth; Thalhammer, Renate; Winkler, Stefan; Blüml, Stephan; Stiasny, Karin; Aberle, Judith H; Smolen, Josef S; Heinz, Leonhard X; Aletaha, Da... Journal: Annals of the rheumatic diseases Issue: Volume 80:Issue 10(2021) Page Start: 1345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The First Case of Usutu Virus Neuroinvasive Disease in Austria, 2021. (16th May 2022) Authors: Graninger, Marianne; Hubmer, Stefan; Riederer, Franz; Kettner, Stephan; Hauk, Martin; Auf, Tasnim; Aberle, Judith H; Stiasny, Karin; Aberle, Stephan W; Camp, Jeremy V Journal: Open forum infectious diseases Issue: Volume 9:Number 7(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗